Glecaprevir Good Manufacturer supply High Quality 1365970-03-1
- Molecular Formula:C38H46F4N6O9S
- Molecular Weight:838.87
- PKA:4.46±0.40(Predicted)
- PSA：203.60000
- Density:1.46±0.1 g/cm3(Predicted)
- LogP:5.98610
Glecaprevir (1365970-03-1) Usage
Glecaprevir is an antiviral medication specifically designed to target and inhibit the hepatitis C virus (HCV) nonstructural (NS) protein 3/4A protease. This enzyme plays a crucial role in the replication and assembly of the virus within host cells. Developed collaboratively by AbbVie and Enanta Pharmaceuticals, Glecaprevir has demonstrated potent antiviral activity against various HCV genotypes and offers a high barrier to resistance in vitro. It is particularly beneficial for patients with chronic kidney disease who are also suffering from HCV.
How to get the best price on Glecaprevir?
Zibo Hangyu Biotechnology Development Co., Ltd is a quality supplier and manufacturer of Glecaprevir . You can buy high quality, low price Glecaprevir 1365970-03-1 here.
Zibo Hangyu Biotechnology Development Co., Ltd. is a comprehensive chemical enterprise focusing on fine chemical products and pharmaceutical intermediates, integrating research and development, production and sales. The company is equipped with advanced equipment quality inspection and research center. At the same time, the company has excellent talents with rich experience in process development and quality control. To provide customers with total solutions from raw material processing to chemical synthesis systems. The company has established a standardized and perfect quality standard system to provide stable and high quality production and service.
Milestones
- 2012yearThe company was founded, began to engage in the production and supply of chemical raw materials
- 2014yearExpand the scale of production, pharmaceutical raw materials production workshop was established
- 2016yearCooperated with domestic and foreign chemical platforms to promote self-produced and high-end pharmaceutical intermediates
- 2019yearIn recent years to participate in the international pharmaceutical raw materials exhibitions
- 2023yearBusiness continues to expand, Production and Sales teams continue to grow
- 2026yearPlans to set up foreign branches
